|

AUCD Community Inclusion

AUCD’s Community Inclusion Team supports the University Centers for Excellence in Developmental Disabilities (UCEDD) Network in partnership with the Administration for Community Living.

Learn More
|

AUCD Maternal and Child Health Engagement

AUCD’s Maternal and Child Health Engagement supports the Autism CARES Programs, including LEND and DBP Programs.

Learn More
|

AUCD Public Health

AUCD’s Public Health Team works to create health promotion and public health efforts that include people with disabilities.

Learn More
|

AUCD Emerging Leaders Community

AUCD Emerging Leaders are a part of a community that includes trainees, early career professionals, self-advocates, and family members from AUCD member Centers and Programs.

Learn More

Donate

Product

LEND: Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it - submitted

Center:

OR-Oregon Institute on Development & Disability, UCEDD/LEND

Fiscal Year:

2023

Contact Information:

Kristin Knight
[email protected]
503-494-2061

Product Description:

Guideline for clinicians regarding the FDA approval of STS for reduction of cisplatin-induced hearing loss in children. Outlines the evidence that led to the FDA approval risks versus benefits.

Keyword(s):

hearing loss, cisplatin, otoprotectant, sodium thiosulfate, children

Product/Publication Type(s):

Peer-reviewed publications in scholarly journals submitted

Target Audience:

Professionals, Policymakers, Students

Alternative Format:

Electronic (disc, CD, 508 compliant web posting)

To Obtain Copies (URL or Email):

COVID-19 Related Data:

N/A

1100 Wayne Avenue, Suite 1000 Silver Spring, MD 20910